Hi Tank.
Again speculation on my part & the bellow is purely hypothetical but I'm thinking .
That CGB made the original deal with Medcann knowing ahead of shareholders that the Bonify deal was in the works.
We did vote yes to the original proposal without knowledge of the Bonify deal however after Bonify's legal problems I'm speculating that CGB attempted to amend the proposal with Medcann.
It's very likely imo that CGB management proposed to still aquire Medcann however divert the cr funds in the near term into the BioHealth project due to the risk now associated with the Bonify partnership.
We may have voted yes to the Medcann deal with no knowledge of Bonify at the time because despite the risk other viable alternatives were not on the table.
There is every chance Medcann have decided not to proceed with the acquisition at the disappointment of not having their fit-out fully funded. If this was the case perfectly understandable.
We then had CGB & Medcann engineer a new proposal that still see's them as business partners, just in a different capacity.
It's been both a frustrating & exciting 8 months but at the sake of resuming trading or sticking to a proposal would you risk our future over this inconvenience?
Has anyone had a good look at the books? The market? The number of shares that still stand to be on issue?
There isn't much room for wrong turns..We may not get another chance Tank..That's how serious this is!
We need to start generating revenue in the next 2 years..Potentially no more capital raises left in the tank after this!
This isn't monopoly money here.
Thanks though Tank I do enjoy discussing things with you.
- Forums
- ASX - By Stock
- CGB
- CGB - CR fund refund
CGB - CR fund refund, page-17
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online